Feasibility randomised controlled trial of a guided workbook intervention to support work-related goals among cancer survivors in the UK.
cancer
employment
feasibility
intervention
randomised controlled trial
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
21 01 2019
21 01 2019
Historique:
entrez:
24
1
2019
pubmed:
24
1
2019
medline:
30
1
2020
Statut:
epublish
Résumé
Employment following illness is associated with better physical and psychological functioning. This study aimed to assess the feasibility and acceptability of a theoretically led workbook intervention designed to support patients with cancer returning to work. Parallel-group randomised controlled trial with embedded qualitative interviews. Oncology clinics within four English National Health Service Trusts. Patients who had received a diagnosis of breast, gynaecological, prostate or colorectal cancer and who had been receiving treatment for a minimum of two weeks. A self-guided WorkPlan workbook designed to support patients with cancer to return to work with fortnightly telephone support calls to discuss progress. The control group received treatment as usual and was offered the workbook at the end of their 12-month follow-up. We assessed aspects of feasibility including eligibility, recruitment, data collection, attrition, feasibility of the methodology, acceptability of the intervention and potential to calculate cost-effectiveness. The recruitment rate of eligible patients was 44%; 68 participants consented and 58 (85%) completed baseline measures. Randomisation procedures were acceptable, data collection methods (including cost-effectiveness data) were feasible and the intervention was acceptable to participants. Retention rates at 6-month and 12-month follow-up were 72% and 69%, respectively. At 6-month follow-up, 30% of the usual care group had returned to full-time or part-time work (including phased return to work) compared with 43% of the intervention group. At 12 months, the percentages were 47% (usual care) and 68% (intervention). The findings confirm the feasibility of a definitive trial, although further consideration needs to be given to increasing the participation rates among men and black and ethnic minority patients diagnosed with cancer. ISRCTN56342476; Pre-results.
Identifiants
pubmed: 30670507
pii: bmjopen-2018-022746
doi: 10.1136/bmjopen-2018-022746
pmc: PMC6347862
doi:
Banques de données
ISRCTN
['ISRCTN56342476']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e022746Subventions
Organisme : Department of Health
ID : PB-PG-0613-31088
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
BMC Cancer. 2015 Nov 12;15:899
pubmed: 26560707
Trials. 2013 Jun 14;14:175
pubmed: 23768153
Nurs Res. 2009 Nov-Dec;58(6):452-6
pubmed: 19918156
Psychooncology. 2011 Nov;20(11):1236-41
pubmed: 20821375
Soc Sci Med. 1995 Nov;41(10):1447-62
pubmed: 8560313
Cancer. 2011 Jun 15;117(12):2779-90
pubmed: 21495026
J Clin Psychol. 1999 Oct;55(10):1243-54
pubmed: 11045774
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
BMJ. 2008 Oct 22;337:a1937
pubmed: 18945728
Cochrane Database Syst Rev. 2015 Sep 25;(9):CD007569
pubmed: 26405010
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Psychooncology. 2013 Mar;22(3):659-67
pubmed: 22434715
Med Care Res Rev. 2006 Apr;63(2):217-35
pubmed: 16595412
BMC Psychol. 2017 Oct 4;5(1):34
pubmed: 28978353
JMIR Res Protoc. 2016 May 03;5(2):e75
pubmed: 27143229
JAMA. 2009 Feb 18;301(7):753-62
pubmed: 19224752
J Behav Health Serv Res. 2012 Oct;39(4):374-96
pubmed: 22935907
Occup Med (Lond). 2010 Dec;60(8):611-7
pubmed: 20855546
BMJ Open. 2012 Jul 10;2(4):
pubmed: 22786950
Psychooncology. 2013 Jun;22(6):1208-19
pubmed: 22888070
Qual Life Res. 2004 Mar;13(2):311-20
pubmed: 15085903
Psychooncology. 2002 Mar-Apr;11(2):124-31
pubmed: 11921328
Int J Psychiatry Med. 2010;40(2):163-81
pubmed: 20848873
BMC Med Res Methodol. 2014 Jan 23;14:10
pubmed: 24456229
BMC Public Health. 2013 Jan 05;13:6
pubmed: 23289708
Acta Oncol. 2007;46(4):446-51
pubmed: 17497311
Eur J Cancer. 2009 Apr;45(6):1042-66
pubmed: 19124239
Soc Sci Med. 2000 Jul;51(2):243-9
pubmed: 10832571
Health Econ. 2007 Jul;16(7):719-37
pubmed: 17177273
Eur J Cancer. 1997 Sep;33(10):1597-604
pubmed: 9389921